{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:05:49Z","timestamp":1794330349936,"version":"4.9.0"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004101","name":"Lady Tata Memorial Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research\/Reviews in Mutation Research"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.mrrev.2021.108387","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T13:08:01Z","timestamp":1623330481000},"page":"108387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Borderline HbA2 levels: Dilemma in diagnosis of beta-thalassemia carriers"],"prefix":"10.1016","volume":"788","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4083-9815","authenticated-orcid":false,"given":"Stacy","family":"Colaco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Nadkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrrev.2021.108387_bib0005","series-title":"The Thalassemia Syndromes","author":"Weatherall","year":"2001"},{"key":"10.1016\/j.mrrev.2021.108387_bib0010","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2017.018","article-title":"\u03b2-Thalassemia distribution in the old world: an ancient disease seen from a historical standpoint","volume":"9","author":"De Sanctis","year":"2017","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"10.1016\/j.mrrev.2021.108387_bib0015","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011700","article-title":"The molecular basis of \u03b2-thalassemia","volume":"3","author":"Thein","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.mrrev.2021.108387_bib0020","article-title":"Advances in genome editing: the technology of choice for precise and efficient \u03b2-thalassemia treatment","volume":"30","author":"Ali","year":"2020","journal-title":"Gene Ther."},{"key":"10.1016\/j.mrrev.2021.108387_bib0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/GIM.0b013e3181cd68ed","article-title":"Beta-thalassemia","volume":"12","author":"Cao","year":"2010","journal-title":"Genet. Med."},{"key":"10.1016\/j.mrrev.2021.108387_bib0030","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/j.clinbiochem.2009.06.026","article-title":"The significance of the hemoglobin A2 value in screening for hemoglobinopathies","volume":"42","author":"Giambona","year":"2009","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.mrrev.2021.108387_bib0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/jcp.2008.056945","article-title":"The role of haemoglobin A2 testing in the diagnosis of thalassaemias and related haemoglobinopathies","volume":"62","author":"Mosca","year":"2009","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0040","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/bjh.13570","article-title":"HbA2: biology, clinical relevance and a possible target for ameliorating sickle cell disease","volume":"170","author":"Steinberg","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/bjh.12084","article-title":"HbA2 levels in normal adults are influenced by two distinct genetic mechanisms","volume":"160","author":"Menzel","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0050","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ajh.2830460204","article-title":"Genotype of subjects with borderline hemoglobin A2 levels: implication for, \u03b2\u2010thalassemia carrier screening","volume":"46","author":"Galanello","year":"1994","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0055","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1515\/CCLM.2007.002","article-title":"External quality assessment of hemoglobin A2 measurement: data from an Italian pilot study with fresh whole blood samples and commercial HPLC systems","volume":"45","author":"Paleari","year":"2007","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.mrrev.2021.108387_bib0060","series-title":"Prevention of Thalassaemias and Other Haemoglobin Disorders, Vol. 2. Laboratory Protocols","author":"Old","year":"2012"},{"key":"10.1016\/j.mrrev.2021.108387_bib0065","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000321046","article-title":"Co-inheritance of \u03b2-and \u03b4-thalassemia compromising prenatal screening in a Chinese couple seeking prevention","volume":"30","author":"Li","year":"2011","journal-title":"Fetal. Diagn. Ther."},{"key":"10.1016\/j.mrrev.2021.108387_bib0070","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.cca.2012.05.019","article-title":"Compromising for carrier detection of beta thalassemia based on measurement of HbA2 levels in unusual cases","volume":"413","author":"Colaco","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.mrrev.2021.108387_bib0075","first-page":"298","article-title":"Standardization of the HbA2 assay","volume":"29","author":"Paleari","year":"2018","journal-title":"EJIFCC."},{"key":"10.1016\/j.mrrev.2021.108387_bib0080","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/ijlh.12413","article-title":"ICSH recommendations for assessing automated high\u2010performance liquid chromatography and capillary electrophoresis equipment for the quantitation of HbA2","volume":"37","author":"Stephens","year":"2015","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0085","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bioelechem.2008.04.010","article-title":"New analytical tools and epidemiological data for the identification of HbA2 borderline subjects in the screening for beta-thalassemia","volume":"73","author":"Mosca","year":"2008","journal-title":"Bioelectrochemistry."},{"key":"10.1016\/j.mrrev.2021.108387_bib0090","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.4081\/thal.2012.e4","article-title":"Role of novel and rare nucleotide substitutions of the \u03b2-globin gene","volume":"2","author":"Vinciguerra","year":"2012","journal-title":"Thalass. Rep."},{"key":"10.1016\/j.mrrev.2021.108387_bib0095","first-page":"25","article-title":"The molecular basis of normal HbA2 (type 2) beta-thalassemia in Greece","volume":"8","author":"Tzetis","year":"1994","journal-title":"Hematol. Pathol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0100","doi-asserted-by":"crossref","first-page":"230","DOI":"10.5114\/aoms.2018.72245","article-title":"KLF1 gene and borderline hemoglobin A2 in Saudi population","volume":"14","author":"Borgio","year":"2018","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.mrrev.2021.108387_bib0105","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1080\/03007995.2018.1435520","article-title":"Hemoglobin A2 (HbA2) has a measure of unreliability in diagnosing \u03b2-thalassemia trait (\u03b2-TT)","volume":"34","author":"Al-Amodi","year":"2018","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.mrrev.2021.108387_bib0110","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/858294","article-title":"Hemoglobin A2 lowered by Iron deficiency and \u03b1 -Thalassemia: should screening recommendation for \u03b2 -Thalassemia change?","author":"Denic","year":"2013","journal-title":"ISRN Hematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0115","first-page":"167","article-title":"Cap+ 1 mutation; an unsuspected cause of beta thalassaemia transmission in Pakistan","volume":"26","author":"Karim","year":"2009","journal-title":"Turk. J. Haematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0120","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/03630269.2013.785434","article-title":"Silent \u03b2-thalassemia mutations at -101 (C&T) and -71 (C&T) and their coinheritance with the sickle cell mutation in Bahrain","volume":"37","author":"Al Moamen","year":"2013","journal-title":"Hemoglobin"},{"key":"10.1016\/j.mrrev.2021.108387_bib0125","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s12098-007-0117-8","article-title":"HPLC studies in hemoglobinopathies. Symposium: newer diagnostic tests","volume":"74","author":"Colah","year":"2007","journal-title":"Indian J Pediatr."},{"key":"10.1016\/j.mrrev.2021.108387_bib0130","first-page":"6","article-title":"Globin gene defects in normal and borderline haemoglobin A2 levels: an IMR experience","volume":"2","author":"Zamri","year":"2018","journal-title":"JBCS"},{"key":"10.1016\/j.mrrev.2021.108387_bib0135","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bcmd.2018.10.002","article-title":"Borderline hemoglobin A2 levels in northern Thai population: HBB genotypes and effects of coinherited alpha-thalassemia","volume":"74","author":"Chaweephisal","year":"2019","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.mrrev.2021.108387_bib0140","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000442194","article-title":"The problem of borderline hemoglobin A2 levels in the screening for \u03b2-thalassemia carriers in sardinia","volume":"135","author":"Paglietti","year":"2016","journal-title":"Acta Haematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0145","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/03630269.2020.1826327","article-title":"Molecular characterization of \u03b2-and \u03b1-Globin gene mutations in individuals with borderline hb A2 levels","author":"Satthakarn","year":"2020","journal-title":"Hemoglobin"},{"key":"10.1016\/j.mrrev.2021.108387_bib0150","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bcmd.2014.04.005","article-title":"Delineation of the molecular basis of borderline hemoglobin A2 in Chinese individuals","volume":"53","author":"Lou","year":"2014","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.mrrev.2021.108387_bib0155","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/03630269.2018.1509869","article-title":"Analysis of the genotypes in a chinese population with increased hb A2 and low hematological indices","volume":"42","author":"Jiang","year":"2018","journal-title":"Hemoglobin"},{"key":"10.1016\/j.mrrev.2021.108387_bib0160","first-page":"2165","article-title":"Hemoglobin A2: origin, evolution, and aftermath","volume":"78","author":"Steinberg","year":"1991","journal-title":"Blood."},{"key":"10.1016\/j.mrrev.2021.108387_bib0165","first-page":"2","article-title":"HbA2 measurements in \u03b2-thalassemia and in other conditions","volume":"29","author":"Ivaldi","year":"2014","journal-title":"Thalass. Rep."},{"key":"10.1016\/j.mrrev.2021.108387_bib0170","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1258\/0004563021901720","article-title":"Molecular analysis of a Thai \u03b2-thalassaemia heterozygote with normal haemoglobin A2 level: implication for population screening","volume":"39","author":"Fucharoen","year":"2002","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.mrrev.2021.108387_bib0175","first-page":"129","article-title":"Known and new delta globin gene mutations and their diagnostic significance","volume":"91","author":"Bouva","year":"2006","journal-title":"Haematologica."},{"key":"10.1016\/j.mrrev.2021.108387_bib0180","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1182\/blood-2011-04-345736","article-title":"KLF1 gene mutations cause borderline HbA2","volume":"118","author":"Perseu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.mrrev.2021.108387_bib0185","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1515\/CCLM.2011.696","article-title":"\u03b2-Thalassemia mutations in subjects with borderline HbA2 values: a pilot study in North India","volume":"49","author":"Rangan","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.mrrev.2021.108387_bib0190","article-title":"Coexisting iron deficiency anemia and Beta thalassemia trait: effect of iron therapy on red cell parameters and hemoglobin subtypes","volume":"12","author":"Verma","year":"2014","journal-title":"ISRN Hematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0195","first-page":"173","article-title":"Masked deficit of vitamin B12 in the patient with heterozygous b-thalassemia and spastic paraparesis","volume":"104","author":"Bilic","year":"2004","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.mrrev.2021.108387_bib0200","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0377-1237(09)80051-8","article-title":"Cation exchange high performance liquid chromatography for diagnosis of haemoglobinopathies","volume":"65","author":"Gupta","year":"2009","journal-title":"Med. J. Armed Forces India"},{"key":"10.1016\/j.mrrev.2021.108387_bib0205","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3109\/23744235.2015.1089592","article-title":"Effect of antiretroviral therapy on hemoglobin A2 values can have implications in antenatal beta-thalassemia screening programs","volume":"48","author":"Bhagat","year":"2016","journal-title":"Infect. Dis."},{"key":"10.1016\/j.mrrev.2021.108387_bib0210","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/ajh.2830430203","article-title":"Increase of hemoglobin A2 in human immunodeficiency virus\u20101\u2010infected patients treated with zidovudine","volume":"43","author":"Routy","year":"1993","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0215","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1210\/jcem-57-2-344","article-title":"Influence of thyroid status on hemoglobin A2 expression","volume":"57","author":"Kuhn","year":"1983","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mrrev.2021.108387_bib0220","first-page":"78","article-title":"The influence of thyroid hormones on hemoglobin a2 and F expression","volume":"5","author":"Jaafar","year":"2009","journal-title":"New Iraqi J. Med."},{"key":"10.1016\/j.mrrev.2021.108387_bib0225","series-title":"Evaluation of UK NEQAS (H) HbA2 and Related Performance Data","author":"Batterbee","year":"2010"},{"key":"10.1016\/j.mrrev.2021.108387_bib0230","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cca.2016.05.023","article-title":"Developing a reference system for the IFCC standardization of HbA2","volume":"476","author":"Paleari","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.mrrev.2021.108387_bib0235","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cca.2020.11.008","article-title":"A roadmap for the standardization of hemoglobin A2","volume":"1","author":"Mosca","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.mrrev.2021.108387_bib0240","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cca.2017.12.001","article-title":"Calibration by commutable control materials is able to reduce inter-method differences of current high-performance methods for HbA2","volume":"477","author":"Paleari","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.mrrev.2021.108387_bib0245","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/ijlh.12966","article-title":"Evaluation of the suitability of the World Health Organization International Reference Reagent for Hb A2 quantitation (89\/666) for continued use","volume":"41","author":"De la Salle","year":"2019","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0250","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2141.1979.tb03703.x","article-title":"The heterogeneity of normal Hb A2-beta thalassaemia in Greece","volume":"42","author":"Kattamis","year":"1979","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0255","first-page":"269","article-title":"Silent thalassemias: genotypes and phenotypes","volume":"82","author":"Bianco","year":"1997","journal-title":"Haematologica."},{"key":"10.1016\/j.mrrev.2021.108387_bib0260","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/bjh.13636","article-title":"Different switching patterns of \u03b2-thalassaemic mutations at the proximal and distal CACCC box of the human HBB (\u03b2-globin) gene","volume":"173","author":"Marongiu","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0265","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000203622","article-title":"Levels of Hb A2 in heterozygotes and homozygotes for beta-thalassemia mutations; influence of mutations in the CACCC and ATAAA motifs of the beta-globin gene promoter","volume":"98","author":"Huisman","year":"1997","journal-title":"Acta Haematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0270","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/jclinpath-2017-204378","article-title":"Phenotype of mutations in the promoter region of the \u03b2-globin gene","volume":"70","author":"Ropero","year":"2017","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0275","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2141.1995.tb05182.x","article-title":"A promoter mutation, C&T at position -92, leading to silent beta-thalassaemia","volume":"90","author":"Rosatelli","year":"1995","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0280","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ajh.1079","article-title":"Normal delta globin gene sequence in carrier of the silent-101 (C-T) beta-thalassemia mutation with normal HbA2 level","volume":"67","author":"Ristaldi","year":"2001","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0285","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1365-2141.2004.05146.x","article-title":"A novel silent beta-thalassemia mutation in the distal CACCC box affects the binding and responsiveness to EKLF","volume":"126","author":"Moi","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0290","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/ajh.21000","article-title":"A novel mutation of the beta-globin gene promoter (-102 C&A) and pitfalls in family screening","volume":"87","author":"Aguilar-Martinez","year":"2007","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0295","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00277-007-0312-8","article-title":"A novel mutation of -73(A&T) in the CCAAT box of the beta-globin gene identified in a patient with the mild beta-thalassemia intermedia","volume":"86","author":"Chen","year":"2007","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0300","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bcmd.2014.11.008","article-title":"A large cohort of \u03b2+-thalassemia in Thailand: molecular, hematological and diagnostic considerations","volume":"54","author":"Yamsri","year":"2015","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.mrrev.2021.108387_bib0305","first-page":"6043","article-title":"A novel \u03b2-globin gene CAP site mutation in association with the 92+ 1G& A mutation was found in a thalassemia intermedia patient","volume":"16","author":"Letitia","year":"2011","journal-title":"Rom. Biotechnol. Lett."},{"key":"10.1016\/j.mrrev.2021.108387_bib0310","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/330384a0","article-title":"Characterization of beta-thalassaemia mutations using direct genomic sequencing of amplified single copy DNA","volume":"330","author":"Wong","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.mrrev.2021.108387_bib0315","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF01715386","article-title":"Clinical heterogeneity of silent-gene \u03b2-thalassemia among Indians","volume":"70","author":"Nadkarni","year":"1995","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0320","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1258\/096914107782066202","article-title":"Assessing the impact of screening and counselling high school children for beta-thalassaemia in India","volume":"14","author":"Colah","year":"2007","journal-title":"J. Med. Screen."},{"key":"10.1016\/j.mrrev.2021.108387_bib0325","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2141.1994.tb05023.x","article-title":"A novel beta-thalassaemia mutation in the 5\u2019 untranslated region of the beta-globin gene","volume":"88","author":"Athanassiadou","year":"1994","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0330","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1365-2141.2001.03071.x","article-title":"Beta-Thalassaemia intermedia in a Turkish girl: homozygosity for G-->A substitution at +22 relative to the beta-globin cap site","volume":"115","author":"Oner","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0335","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1365-2141.2004.04835.x","article-title":"Thalassaemia mutations within the 5\u2019UTR of the human beta-globin gene disrupt transcription","volume":"124","author":"Sgourou","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0340","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1365-2141.2003.04754.x","article-title":"\u03b2+45 G& C: a novel silent \u03b2-thalassaemia mutation the first in the Kozak sequence","volume":"124","author":"De","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0345","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2141.1991.tb04396.x","article-title":"A novel beta-thalassaemia mutation: deletion of 4 bp (-AAAC) in the 5\u2019 transcriptional sequence","volume":"78","author":"Huang","year":"1991","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0350","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00277-008-0651-0","article-title":"The 4-bp deletion (-AAAC) in the 5\u2032 untranslated region of the \u03b2-globin gene: a simple polymorphism?","volume":"88","author":"Li","year":"2009","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0355","doi-asserted-by":"crossref","first-page":"D537","DOI":"10.1093\/nar\/gkh006","article-title":"Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies","volume":"32","author":"Patrinos","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mrrev.2021.108387_bib0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103020","article-title":"IthaGenes: an interactive database for haemoglobin variations and epidemiology","volume":"9","author":"Kountouris","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.mrrev.2021.108387_bib0365","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/humu.21438","article-title":"LOVD v.2.0: the next generation in gene variant databases","volume":"32","author":"Fokkema","year":"2011","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.mrrev.2021.108387_bib0370","first-page":"25","article-title":"The molecular basis of normal HbA2 (type 2) beta-thalassemia in Greece","volume":"8","author":"Tzetis","year":"1994","journal-title":"Hematol. Pathol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0375","first-page":"551","article-title":"A new polyadenylation site mutation associated with a mild beta-thalassemia phenotype","volume":"90","author":"Giordano","year":"2005","journal-title":"Haematologica."},{"key":"10.1016\/j.mrrev.2021.108387_bib0380","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3109\/03630269.2011.654144","article-title":"Is the poly A (T& C) mutation a causative factor for misdiagnosis in second trimester prenatal diagnosis of \u03b2-thalassemia by fetal blood analysis on high performance liquid chromatography?","volume":"36","author":"Italia","year":"2012","journal-title":"Hemoglobin"},{"key":"10.1016\/j.mrrev.2021.108387_bib0385","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-0609.2012.01810.x","article-title":"Variable haematological and clinical presentation of \u03b2\u2010thalassaemia carriers and homozygotes with the Poly A (T&C) mutation in the Indian population","volume":"89","author":"Italia","year":"2012","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0390","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12687-011-0069-6","article-title":"Screening for the beta-thalassaemia trait: hazards among populations of West African Ancestry","volume":"3","author":"Gibson","year":"2012","journal-title":"J. Community Genet."},{"key":"10.1016\/j.mrrev.2021.108387_bib0395","first-page":"289","article-title":"A C&G mutation at nt position 6 3\u2019 to the terminating codon may be the cause of a silent beta-thalassemia","volume":"54","author":"Jankovic","year":"1991","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0400","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1046\/j.1365-2141.2002.03627.x","article-title":"The beta-globin C-->G mutation at 6 bp 3\u2019 to the termination codon causes beta-thalassaemia by decreasing the mRNA level","volume":"118","author":"Sgourou","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0405","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1751-553X.2012.01456.x","article-title":"Two novel mutations in the 3\u2019 untranslated region of the beta-globin gene that are associated with the mild phenotype of beta thalassemia","volume":"35","author":"Bilgen","year":"2013","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0410","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF00218918","article-title":"The T>C mutation at position +96 of the untranslated region 3\u2019 to the terminating codon of the beta-globin gene is a rare polymorphism that does not cause a beta-thalassemia as previously ascribed","volume":"93","author":"Divoky","year":"1994","journal-title":"Hum. Genet."},{"key":"10.1016\/j.mrrev.2021.108387_bib0415","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/ijlh.12433","article-title":"Co-heredity of silent CAP + 1570 T>C (HBB:c*96T>C) defect and severe \u03b2-thal mutation: a cause of mild \u03b2-thalassemia intermedia","volume":"38","author":"Vinciguerra","year":"2016","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0420","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/03630269.2014.995805","article-title":"Identification of a Novel Mutation in the \u03b2 Globin Gene 30 Untranslated Region (HBB: c.*+118A4G) in Spain","volume":"39","author":"Herrera","year":"2015","journal-title":"Hemoglobin"},{"key":"10.1016\/j.mrrev.2021.108387_bib0425","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1515\/cclm-2016-0470","article-title":"Detection of the common South-East Asian \u03b20-thalassemia mutations in samples with borderline HbA2 levels","volume":"55","author":"Rungsee","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.mrrev.2021.108387_bib0430","first-page":"2","article-title":"The diagnosis of Beta thalassemia with borderline HbA2 level among Kelantan population","volume":"8","author":"Rosnah","year":"2017","journal-title":"J. Blood Disord. Transfus."},{"key":"10.1016\/j.mrrev.2021.108387_bib0435","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bcmd.2004.05.002","article-title":"Impact of beta globin gene mutations on the clinical phenotype of beta thalassemia in India","volume":"33","author":"Colah","year":"2004","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.mrrev.2021.108387_bib0440","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ajh.1156","article-title":"Molecular pathogenesis and clinical variability of \u03b2\u2010thalassemia syndromes among Indians","volume":"68","author":"Nadkarni","year":"2001","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0445","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(17)31822-6","article-title":"Thalassaemia","volume":"391","author":"Taher","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.mrrev.2021.108387_bib0450","first-page":"129","article-title":"Alpha-thalassaemia in association with beta-thalassaemia patients in Malaysia: a study on the co-inheritance of both disorders","volume":"11","author":"Wee","year":"2008","journal-title":"Community Genet."},{"key":"10.1016\/j.mrrev.2021.108387_bib0455","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.gene.2018.02.058","article-title":"Molecular characterization of \u03b1- and \u03b2-thalassemia in the Yulin region of Southern China","volume":"655","author":"He","year":"2018","journal-title":"Gene."},{"key":"10.1016\/j.mrrev.2021.108387_bib0460","first-page":"59","article-title":"Co-inheritance of alpha-and beta-thalassemia in Khuzestan Province","volume":"13","author":"Rahim","year":"2008","journal-title":"Iran. J. Ped. Hematol. Oncol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0465","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/jmg.15.6.448","article-title":"Thalassaemia of intermediate severity resulting from the interaction between alpha- and beta-thalassaemia","volume":"15","author":"Musumeci","year":"1978","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.mrrev.2021.108387_bib0470","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/03630269.2015.1016615","article-title":"Hb Lansing (HBA2: c.264C > G) and a new \u03b2 promoter transversion [-52 (G > T)]: an attempt to define the phenotype of two mutations found in the Omani population","volume":"39","author":"Hassan","year":"2015","journal-title":"Hemoglobin"},{"key":"10.1016\/j.mrrev.2021.108387_bib0475","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/03630260903081323","article-title":"First identification of a point mutation at position -83 (G>A) of the beta-globin gene promoter","volume":"33","author":"Cadet","year":"2009","journal-title":"Hemoglobin"},{"key":"10.1016\/j.mrrev.2021.108387_bib0480","article-title":"Beta thalassemia IVS-I-5(G-->C) heterozygosity masked by the presence of HbJ-Meerut in a Dutch-Indian patient","volume":"91","author":"Giordano","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.mrrev.2021.108387_bib0485","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ajh.20083","article-title":"High frequency of deletional alpha-thalassemia in beta-thalassemia trait: implications for genetic counseling","volume":"76","author":"Panigrahi","year":"2004","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0490","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s00277-015-2479-8","article-title":"Colah RB Diverse phenotypes and transfusion requirements due to interaction of \u03b2-thalassemias with triplicated \u03b1-globin genes","volume":"94","author":"Mehta","year":"2015","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0495","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/03630269.2011.571527","article-title":"The carrier frequency of \u03b1-globin gene triplication in an Iranian population with normal or borderline hematological parameters","volume":"35","author":"Moosavi","year":"2011","journal-title":"Hemoglobin"},{"key":"10.1016\/j.mrrev.2021.108387_bib0500","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3324\/haematol.10785","article-title":"A 65 bp duplication\/insertion in exon II of the beta globin gene causing beta0-thalassemia","volume":"92","author":"Frischknecht","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.mrrev.2021.108387_bib0505","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/03630269.2018.1495648","article-title":"Compound Heterozygosity for Silent Cap+ 1570 (T>C)(HBB: c* 96T> C), Codon 39 (C> T)(HBB: c. 118C> T) and the Presence of \u03b1\u03b1\u03b1 anti\u20133.7\/\u03b1\u03b1 in Greece. A Case Presentation","volume":"42","author":"Theodoridou","year":"2018","journal-title":"Hemoglobin"},{"key":"10.1016\/j.mrrev.2021.108387_bib0510","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/03630260902827684","article-title":"Frequency of alpha-globin gene triplications and their interaction with beta-thalassemia mutations","volume":"124","author":"Giordano","year":"2009","journal-title":"Hemoglobin"},{"key":"10.1016\/j.mrrev.2021.108387_bib0515","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/pd.4706","article-title":"Challenges in prenatal diagnosis of beta thalassaemia: couples with normal HbA2 in one partner","volume":"35","author":"Gorivale","year":"2015","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.mrrev.2021.108387_bib0520","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.bcmd.2007.11.006","article-title":"Segmental duplications involving the \u03b1-globin gene cluster are causing \u03b2-thalassemia intermedia phenotypes in \u03b2-thalassemia heterozygous patients","volume":"40","author":"Harteveld","year":"2008","journal-title":"Blood Cells Mols Dis."},{"key":"10.1016\/j.mrrev.2021.108387_bib0525","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/03630269.2015.1012678","article-title":"Association of an \u03b1-Globin gene cluster duplication and heterozygous \u03b2-Thalassemia in a patient with a severe thalassemia syndrome","volume":"39","author":"Jiang","year":"2015","journal-title":"Hemoglobin"},{"key":"10.1016\/j.mrrev.2021.108387_bib0530","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ajh.2830450113","article-title":"A novel mediterranean \u201c\u03b4\u03b2\u2010thalassemia\u201d determinant containing the \u03b4+ 27 and \u03b2\u00b0 39 point mutations in cis","volume":"45","author":"Oggiano","year":"1994","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0535","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2141.1991.tb04460.x","article-title":"A novel \u03b4o mutation in cis with Hb Knossos: a study of different genetic interactions in three Egyptian families","volume":"78","author":"Olds","year":"1991","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0540","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1182\/blood.V77.9.2087.2087","article-title":"Molecular basis of the delta thalassemia in cis to hemoglobin Knossos variant","volume":"77","author":"Loudianos","year":"1991","journal-title":"Blood."},{"key":"10.1016\/j.mrrev.2021.108387_bib0545","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/03630269.2010.511586","article-title":"Genotype-phenotype relationship of the \u03b4-thalassemia and Hb A2 variants: observation of 52 genotypes","volume":"34","author":"Lacerra","year":"2010","journal-title":"Hemoglobin."},{"key":"10.1016\/j.mrrev.2021.108387_bib0550","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1600-0609.2007.00949.x","article-title":"Mutational spectrum of delta\u2010globin gene in the Portuguese population","volume":"79","author":"Morgado","year":"2007","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0555","first-page":"8","article-title":"First report on the co-inheritance of beta-globin IVS-I-5 (G> C) thalassemia with delta globin CD12 {Asn> Lys (AAT>AAA)} HbA\u2082-NYU in Iran","volume":"14","author":"Amirian","year":"2011","journal-title":"Arch. Iran. Med."},{"key":"10.1016\/j.mrrev.2021.108387_bib0560","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4236\/ijcm.2012.37113","article-title":"Co-inheritance of beta & delta-globin gene (HbYialousa) mutations in an iranian \u03b2-thalassemia carrier","volume":"3","author":"Valaei","year":"2012","journal-title":"Int. J. Clin. Med."},{"key":"10.1016\/j.mrrev.2021.108387_bib0565","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3109\/03630269.2011.557172","article-title":"Hb A2 Hong Kong\u2013a novel \u03b4-globin variant in a Chinese family masks the diagnosis of \u03b2-thalassemia trait","volume":"35","author":"So","year":"2011","journal-title":"Hemoglobin"},{"key":"10.1016\/j.mrrev.2021.108387_bib0570","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ajh.10423","article-title":"\u03b2\u2010thalassemia in association with a new \u03b4\u2010chain hemoglobin variant [\u03b4116 (g18) Arg\u2192 Leu]: Implications for carrier screening and prenatal diagnosis","volume":"74","author":"Waye","year":"2003","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0575","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3109\/03630269.2010.511591","article-title":"New and known \u03b2-thalassemia determinants masked by known and new \u03b4 gene defects [Hb A2-Ramallah or \u03b46 (A3) Glu\u2192 Gln, G AG>> C AG]","volume":"34","author":"Phylipsen","year":"2010","journal-title":"Hemoglobin"},{"key":"10.1016\/j.mrrev.2021.108387_bib0580","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/03630269.2013.852568","article-title":"Masking of a beta thalassaemia determinant by a novel delta globin defect [HbA2- Saurashtra or \u03b4100(G2)Pro>Ser, HBDc.301C>T] in cis","volume":"38","author":"Colaco","year":"2014","journal-title":"Hemoglobin"},{"key":"10.1016\/j.mrrev.2021.108387_bib0585","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2141.1977.tb00986.x","article-title":"Heterocellular hereditary persistence of fetal haemoglobin (heterocellular HPFH) and its interaction with \u03b2 thalassaemia","volume":"36","author":"Wood","year":"1977","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0590","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2141.2003.04600.x","article-title":"Heterocellular hereditary persistence of fetal haemoglobin affects the haematological parameters of \u03b2-thalassaemia trait","volume":"123","author":"Garner","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0595","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/ijlh.12356","article-title":"Kr\u00fcppel\u2010like factor 1: hematologic phenotypes associated with KLF1 gene mutations","volume":"37","author":"Waye","year":"2015","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0600","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.ygeno.2018.11.032","article-title":"Differential role of Kruppel like factor 1 (KLF1) gene in red blood cell disorders","volume":"111","author":"Hariharan","year":"2019","journal-title":"Genomics"},{"key":"10.1016\/j.mrrev.2021.108387_bib0605","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/ahg.12191","article-title":"Does the Novel KLF1 Gene Mutation Lead to a Delay in Fetal Hemoglobin Switch?","volume":"81","author":"Hariharan","year":"2017","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.mrrev.2021.108387_bib0610","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1182\/blood-2008-03-145672","article-title":"Mutations in EKLF\/KLF1 form the molecular basis of the rare blood group In(Lu) phenotype","volume":"12","author":"Singleton","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.mrrev.2021.108387_bib0615","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1182\/blood-2013-09-526087","article-title":"Mutations in Kr\u00fcppel-like factor 1 cause transfusion-dependent hemolytic anemia and persistence of embryonic globin gene expression","volume":"123","author":"Viprakasit","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.mrrev.2021.108387_bib0620","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF01633952","article-title":"Relationship between Hb and HbA 2 concentrations in healthy and iron deficient subjects","volume":"30","author":"Cartei","year":"1975","journal-title":"Blut"},{"key":"10.1016\/j.mrrev.2021.108387_bib0625","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/jmg.9.2.154","article-title":"Serum iron and unsaturated iron-binding capacity in the-thalassaemia trait: their relation to the levels of haemoglobins A, A 2, and F","volume":"9","author":"Kattamis","year":"1972","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.mrrev.2021.108387_bib0630","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2257.2002.00464.x","article-title":"The effect of iron deficiency anemia on the levels of haemoglobin subtypes: possible consequences for clinical diagnosis","volume":"24","author":"El\u2010Agouza","year":"2002","journal-title":"Clin. Lab. Haematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0635","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0377-1237(08)80005-6","article-title":"Spectrum of haemoglobinopathies in a tertiary care hospital of armed forces","volume":"64","author":"Chopra","year":"2008","journal-title":"Med. J. Armed Forces India"},{"key":"10.1016\/j.mrrev.2021.108387_bib0640","first-page":"200","article-title":"Impact of Iron deficiency anemia on HbA2 levels","author":"Yavarian","year":"2011","journal-title":"J. Appl. Hematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0645","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3109\/03630268108991694","article-title":"Hemoglobin A2 in iron deficient \u03b2-thalassemia heterozygotes","volume":"5","author":"Galanello","year":"1981","journal-title":"Hemoglobin"},{"key":"10.1016\/j.mrrev.2021.108387_bib0650","first-page":"77","article-title":"Haemoglobin A2 levels in iron deficiency anemia","volume":"73","author":"Kurlekar","year":"1981","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.mrrev.2021.108387_bib0655","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3324\/haematol.2011.052357","article-title":"Iron deficiency does not compromise the diagnosis of high HbA2 \u03b2 thalassemia trait","volume":"97","author":"Passarello","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.mrrev.2021.108387_bib0660","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ajh.22188","article-title":"Is HbA2 level a reliable diagnostic measurement for \u03b2\u2010thalassemia trait in people with iron deficiency?","volume":"87","author":"Verhovsek","year":"2012","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0665","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/ijlh.12246","article-title":"Impact of iron deficiency on hemoglobin A2% in obligate \u03b2\u2010thalassemia heterozygotes","volume":"37","author":"Sharma","year":"2015","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.mrrev.2021.108387_bib0670","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s002770050421","article-title":"Phenotypic expression of hemoglobin A2 in beta-thalassemia trait with iron deficiency","volume":"77","author":"Madan","year":"1998","journal-title":"Ann. Hematol."}],"container-title":["Mutation Research\/Reviews in Mutation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383574221000247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383574221000247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T10:26:16Z","timestamp":1761301576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383574221000247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":134,"alternative-id":["S1383574221000247"],"URL":"https:\/\/doi.org\/10.1016\/j.mrrev.2021.108387","relation":{},"ISSN":["1383-5742"],"issn-type":[{"value":"1383-5742","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Borderline HbA2 levels: Dilemma in diagnosis of beta-thalassemia carriers","name":"articletitle","label":"Article Title"},{"value":"Mutation Research\/Reviews in Mutation Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mrrev.2021.108387","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108387"}}